Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Chung

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2009
Removal of gadolinium by dialysis: review of different strategies and techniquesJeffrey I Silberzweig, Miriam Chung
Rheumatic Diseases Clinics of North America|October 3, 2018
Therapy for Proliferative Lupus NephritisKristin Meliambro, Kirk N Campbell, Miriam Chung
Advances in Kidney Disease and Health|July 14, 2024
Membranoproliferative Glomerulonephritis Pattern of InjurySamuel Mon-Wei Yu, Margaret Deoliveira, Miriam Chung, et al.
Journal of Nephrology|January 17, 2014
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathyCholi Hartono, Miriam Chung, Sheng F Kuo, et al.
Kidney Medicine|July 19, 2021
IgA Nephropathy After SARS-CoV-2 VaccinationMatthew Abramson, Samuel Mon-Wei Yu, Kirk N Campbell, et al.
Kidney International Reports|August 2, 2021
Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 VaccineFadi Salem, Joshua L Rein, Samuel Mon-Wei Yu, et al.
The American Journal of Medicine|February 22, 2020
A Case of Dual Positive Glomerulonephritis With Plasma Cell DyscrasiaTakayuki Yamada, Hirotaka Miyashita, Mohamed Rasheed, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 2008
Rituximab treatment of fibrillary glomerulonephritisMichael Collins, Sankar D Navaneethan, Miriam Chung, et al.
Kidney International Reports|July 11, 2018
Bortezomib for Reduction of Proteinuria in IgA NephropathyCholi Hartono, Miriam Chung, Alan S Perlman, et al.
Nephron|April 28, 2026
Rhabdomyolysis and Acute Kidney Injury After the New York City MarathonJordan L Rosenstock, Douglas R Farrell, Steven G Coca, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2009
Removal of gadolinium by dialysis: review of different strategies and techniquesJeffrey I Silberzweig, Miriam Chung
Rheumatic Diseases Clinics of North America|October 3, 2018
Therapy for Proliferative Lupus NephritisKristin Meliambro, Kirk N Campbell, Miriam Chung
Advances in Kidney Disease and Health|July 14, 2024
Membranoproliferative Glomerulonephritis Pattern of InjurySamuel Mon-Wei Yu, Margaret Deoliveira, Miriam Chung, et al.
Journal of Nephrology|January 17, 2014
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathyCholi Hartono, Miriam Chung, Sheng F Kuo, et al.
Kidney Medicine|July 19, 2021
IgA Nephropathy After SARS-CoV-2 VaccinationMatthew Abramson, Samuel Mon-Wei Yu, Kirk N Campbell, et al.
Kidney International Reports|August 2, 2021
Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 VaccineFadi Salem, Joshua L Rein, Samuel Mon-Wei Yu, et al.
The American Journal of Medicine|February 22, 2020
A Case of Dual Positive Glomerulonephritis With Plasma Cell DyscrasiaTakayuki Yamada, Hirotaka Miyashita, Mohamed Rasheed, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 2008
Rituximab treatment of fibrillary glomerulonephritisMichael Collins, Sankar D Navaneethan, Miriam Chung, et al.
Kidney International Reports|July 11, 2018
Bortezomib for Reduction of Proteinuria in IgA NephropathyCholi Hartono, Miriam Chung, Alan S Perlman, et al.
Nephron|April 28, 2026
Rhabdomyolysis and Acute Kidney Injury After the New York City MarathonJordan L Rosenstock, Douglas R Farrell, Steven G Coca, et al.
Pageof 2